Intestinal Failure-Associated Liver Disease: Current Understanding and Recent Advances.

Authors

Sasha-Jane Abi-Aad, Alok Bapatla, Racha T Khalaf

Published in

Clinics in liver disease. Volume 30. Issue 4. Pages 943-960. Epub Sep 04, 2026.

Abstract

Intestinal failure (IF) can result from diverse etiologies, including surgical interventions and congenital defects, often leading to parenteral nutrition dependence. IF-associated liver disease (IFALD) is a serious and life-threatening complication of IF. IFALD is multifactorial leading to cholestasis during phase I, and steatosis and fibrosis during phase II. Diagnosis and screening remain challenging due to the lack of consensus criteria, and management requires a multidisciplinary intestinal rehabilitation approach. Despite these challenges, outcomes including survival and quality of life of patients with IF have improved over the past decade leading to lower rates of liver and small bowel transplants.

PMID:
42946526
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.